What MiRus does
MiRus is a medical technology company developing implants and procedural solutions for cardiovascular and orthopedic disease. Its platform is built around a proprietary molybdenum-rhenium alloy, MoRe, which the company describes as enabling smaller, stronger, and more durable implants with greater biocompatibility and lower metal ion release than traditional materials such as titanium and cobalt chromium.
Key capabilities
MiRus develops products across structural heart, spine, and extremity orthopedics, including a transcatheter aortic valve in clinical trials and spine fusion and orthopedic systems. The company frames its offering as an integrated platform spanning pre-operative, intra-operative, and post-operative care, including remote monitoring, and emphasizes less invasive surgical approaches enabled by its biomaterials.
Who it's for
MiRus serves physicians and hospitals treating patients with conditions such as aortic stenosis, spine disorders, and orthopedic deformities. Its differentiation is more than a decade of research into proprietary Rhenium-based biomaterials applied to durable implants and minimally invasive procedures.